Gene · 6926
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression. | Redox Biol | 2022 | 36209041 | PubTator, text mining | PubMed |
| Upregulation of Metallothionein 1 G (MT1G) Negatively Regulates Ferroptosis in Clear Cell Renal Cell Carcinoma by Reducing Glutathione Consumption. | J Oncol | 2022 | 36204178 | PubTator, text mining | PubMed |
| Immune and inflammation: related factor alterations as biomarkers for predicting prognosis and responsiveness to PD-1 monoclonal antibodies in cervical cancer. | Discov Oncol | 2022 | 36171464 | PubTator, text mining | PubMed |
| New methodology of TMB assessment from tissue and liquid biopsy in NSCLC. | PLoS One | 2022 | 36155654 | PubTator, text mining | PubMed |
| TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis. | Genes (Basel) | 2022 | 36140816 | PubTator, text mining | PubMed |
| The Multi-Omic Landscape of Primary Breast Tumors and Their Metastases: Expanding the Efficacy of Actionable Therapeutic Targets. | Genes (Basel) | 2022 | 36140723 | PubTator, text mining | PubMed |
| Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer. | BMC Cancer | 2022 | 36115953 | PubTator, text mining | PubMed |
| Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer. | Front Cell Dev Biol | 2022 | 36105363 | PubTator, text mining | PubMed |
| Construction of a novel exosomes-related gene signature in hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36105354 | PubTator, text mining | PubMed |
| Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance. | Cell Death Discov | 2022 | 36100611 | PubTator, text mining | PubMed |
| Blastocyst Stage Affects the Isolation and Culture of Buffalo Naive/Primed Embryonic Stem-Like Cells. | Microsc Microanal | 2022 | 36097786 | PubTator, text mining | PubMed |
| SHOX2 refines the identification of human sinoatrial nodal cell population in the in vitro cardiac differentiation. | Regen Ther | 2022 | 36092505 | PubTator, text mining | PubMed |
| The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients. | Front Mol Biosci | 2022 | 36090038 | PubTator, text mining | PubMed |
| Space microgravity improves proliferation of human iPSC-derived cardiomyocytes. | Stem Cell Reports | 2022 | 36084640 | PubTator, text mining | PubMed |
| Differential expression of Ago2-mediated microRNA signaling in adipose tissue is associated with food-induced obesity. | FEBS Open Bio | 2022 | 36062491 | PubTator, text mining | PubMed |
| Tumor suppressors inhibit reprogramming of African spiny mouse ( Acomys) fibroblasts to induced pluripotent stem cells. | Wellcome Open Res | 2022 | 36060301 | PubTator, text mining | PubMed |
| Expression profiles of exosomal tRNA-derived fragments and their biological functions in lipomas. | Front Cell Dev Biol | 2022 | 36035989 | PubTator, text mining | PubMed |
| Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway. | Front Oncol | 2022 | 36033517 | PubTator, text mining | PubMed |
| Timely delivery of cardiac mmRNAs in microfluidics enhances cardiogenic programming of human pluripotent stem cells. | Front Bioeng Biotechnol | 2022 | 36032711 | PubTator, text mining | PubMed |
| CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology. | Mol Biol Rep | 2022 | 36030476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6926/papers?page=20